leisure time -WSS

leisure time

author：explore 2025-09-11 10:30:11 - browse：12

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Adam's Take: Intra

WSS

Steward Health Care expansion into Malta flopped

Readout LOUD podcast, live from the STAT Breakthrough Summit East

STAT Summit: How researchers deal with rejection

Steward Health Care expansion into Malta flopped

ADCs take center stage as promising cancer treatments

Readout LOUD podcast: Live from the 2023 STAT Summit

hotspot

leisure time

hotspot

Medical records are filled with copy

Roche acquires Telavant from Roivant, adding experimental IBD treatment

ChatGPT in medicine: STAT answers readers' burning questions

Cancer, immunology, HIV research ensnared in fetal tissue politics

New air purifier tech could be key to improving indoor air quality

ADCs take center stage as promising cancer treatments

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Erich Jarvis studies song birds to learn about human stuttering

As demand for Covid shots wanes, Moderna seeks its next success

CZI to create biohub to build anti

hotspot

Mirador, a new biotech startup, launches with $400 million

Study on Amgen’s bispecific immunotherapy produces positive data

Adam's Take: Intra

Results on Novartis prostate cancer therapy could expand its use

Smaller biotechs seek to piggyback on weight loss drug boom

With Wegovy coverage, Medicare patients may face high costs

focus

hotspot

focus

explore